246 related articles for article (PubMed ID: 2726106)
1. Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix.
Shingleton HM; Soong SJ; Gelder MS; Hatch KD; Baker VV; Austin JM
Obstet Gynecol; 1989 Jun; 73(6):1027-34. PubMed ID: 2726106
[TBL] [Abstract][Full Text] [Related]
2. Pelvic exenteration for adenocarcinoma of the uterine cervix.
Crozier M; Morris M; Levenback C; Lucas KR; Atkinson EN; Wharton JT
Gynecol Oncol; 1995 Jul; 58(1):74-8. PubMed ID: 7789894
[TBL] [Abstract][Full Text] [Related]
3. Indications for primary and secondary exenterations in patients with cervical cancer.
Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A
Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors for curative pelvic exenterations in patients with recurrent uterine cervical or vaginal cancer.
Sardain H; Lavoué V; Laviolle B; Henno S; Foucher F; Levêque J
Int J Gynecol Cancer; 2014 Nov; 24(9):1679-85. PubMed ID: 25254565
[TBL] [Abstract][Full Text] [Related]
5. Pelvic exenteration for recurrent or persistent cervical cancer: experience of five years at the National Cancer Institute in Mexico.
Terán-Porcayo MA; Zeichner-Gancz I; del-Castillo RA; Beltrán-Ortega A; Solorza-Luna G
Med Oncol; 2006; 23(2):219-23. PubMed ID: 16720922
[TBL] [Abstract][Full Text] [Related]
6. Survival after curative pelvic exenteration for primary or recurrent cervical cancer: a retrospective multicentric study of 167 patients.
Chiantera V; Rossi M; De Iaco P; Koehler C; Marnitz S; Ferrandina G; Legge F; Parazzini F; Scambia G; Schneider A; Vercellino GF
Int J Gynecol Cancer; 2014 Jun; 24(5):916-22. PubMed ID: 24442006
[TBL] [Abstract][Full Text] [Related]
7. Pelvic exenteration for recurrent squamous cell carcinoma of the pelvic organs arising from the cloaca--a single institution's experience over 16 years.
Tan KK; Pal S; Lee PJ; Rodwell L; Solomon MJ
Colorectal Dis; 2013; 15(10):1227-31. PubMed ID: 23714581
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcome of pelvic exenteration in patients with advanced or recurrent uterine cervical cancer.
Tanaka S; Nagase S; Kaiho-Sakuma M; Nagai T; Kurosawa H; Toyoshima M; Tokunaga H; Otsuki T; Utsunomiya H; Takano T; Niikura H; Ito K; Yaegashi N
Int J Clin Oncol; 2014 Feb; 19(1):133-8. PubMed ID: 23404487
[TBL] [Abstract][Full Text] [Related]
9. [Outcomes of perisurgery and short-time follow-up of pelvic exenteration for 17 cases with locally recurrent cervical cancer].
Deng H; Wang JL; Wang ZQ; Li XW; Hu H; Yang B; Zhang XM; Shen K; Guo P; Liang B
Zhonghua Fu Chan Ke Za Zhi; 2020 Apr; 55(4):259-265. PubMed ID: 32375433
[No Abstract] [Full Text] [Related]
10. Robotic-assisted laparoscopic exenteration in recurrent cervical cancer Robotics improved the surgical experience for 2 women with recurrent cervical cancer.
Davis MA; Adams S; Eun D; Lee D; Randall TC
Am J Obstet Gynecol; 2010 Jun; 202(6):663.e1. PubMed ID: 20510970
[TBL] [Abstract][Full Text] [Related]
11. Anterior pelvic exenteration.
Hatch KD; Shingleton HM; Soong SJ; Baker VV; Gelder MS
Gynecol Oncol; 1988 Sep; 31(1):205-16. PubMed ID: 3410348
[No Abstract] [Full Text] [Related]
12. Pelvic exenteration in clear cell adenocarcinoma of the vagina and cervix.
Senekjian EK; Frey K; Herbst AL
Gynecol Oncol; 1989 Sep; 34(3):413-6. PubMed ID: 2767532
[TBL] [Abstract][Full Text] [Related]
13. Does intra-operative radiation at the time of pelvic exenteration improve survival for patients with recurrent, previously irradiated cervical, vaginal, or vulvar cancer?
Backes FJ; Billingsley CC; Martin DD; Tierney BJ; Eisenhauer EL; Cohn DE; O'Malley DM; Salani R; Copeland LJ; Fowler JM
Gynecol Oncol; 2014 Oct; 135(1):95-9. PubMed ID: 25084510
[TBL] [Abstract][Full Text] [Related]
14. [Current status and outcomes of pelvic exenteration for recurrent cervical cancer: a systematic review].
Chen M; Pan L
Zhonghua Fu Chan Ke Za Zhi; 2014 Jun; 49(6):460-5. PubMed ID: 25169641
[TBL] [Abstract][Full Text] [Related]
15. Laparoscopic total pelvic exenteration for cervical cancer relapse.
Pomel C; Rouzier R; Pocard M; Thoury A; Sideris L; Morice P; Duvillard P; Bourgain JL; Castaigne D
Gynecol Oncol; 2003 Dec; 91(3):616-8. PubMed ID: 14675686
[TBL] [Abstract][Full Text] [Related]
16. Laparoscopic assessment improves case selection for exenterative surgery in recurrent cervical and endometrial cancer.
Heath OM; Bryan SJ; Sohaib A; Barton DPJ
J Obstet Gynaecol; 2021 Nov; 41(8):1252-1256. PubMed ID: 33646894
[TBL] [Abstract][Full Text] [Related]
17. Pelvic Exenterations for Advanced and Recurrent Endometrial Cancer: Clinical Outcomes of 40 Patients.
Schmidt AM; Imesch P; Fink D; Egger H
Int J Gynecol Cancer; 2016 May; 26(4):716-21. PubMed ID: 26937752
[TBL] [Abstract][Full Text] [Related]
18. Extended pelvic resections for recurrent uterine and cervical cancer: out-of-the-box surgery.
Caceres A; Mourton SM; Bochner BH; Gerst SR; Liu L; Alektiar KM; Kardos SV; Barakat RR; Boland PJ; Chi DS
Int J Gynecol Cancer; 2008; 18(5):1139-44. PubMed ID: 18053063
[TBL] [Abstract][Full Text] [Related]
19. Exploratory laparotomy in recurrent cervical cancer.
Hardman AA; Daly JW
Obstet Gynecol; 1974 May; 43(5):653-7. PubMed ID: 4822649
[No Abstract] [Full Text] [Related]
20. Pelvic exenteration, University of Michigan: 100 patients at 5 years.
Morley GW; Hopkins MP; Lindenauer SM; Roberts JA
Obstet Gynecol; 1989 Dec; 74(6):934-43. PubMed ID: 2586960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
